LifeStance Health Group, Inc. (NASDAQ:LFST) extended its winning streak to 5 days, gaining 7.93 percent on Thursday, closing at $5.58 per share. The company reported an 84 percent decrease in net loss to $3.8 million and an 11 percent increase in revenue to $345.3 million year-on-year.

LifeStance Health Group, Inc. (NASDAQ:LFST) saw an increase in its clinician base to 7,708 during the period, up by 173 from the first quarter of the year. CEO Dave Bourdon praised the team for achieving double-digit organic revenue growth and a 10 percent adjusted EBITDA margin in the second quarter.

LifeStance Health Group, Inc. (NASDAQ:LFST) reaffirmed its full-year revenue growth target of $1.4 billion to $1.44 billion, as well as adjusted EBITDA of $140 million to $150 million. Investors are advised to consider the potential of LFST as an investment, while also exploring other AI stocks for higher returns.

Read more at Yahoo Finance: LifeStance (LFST) Extends Rally to 5th Day on Strong Investor Confidence